PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jargspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
J Assist Reprod Genet. 1997 April; 14(4): 230–233.
PMCID: PMC3454693

Bilateral serous cystadenofibromas clinically simulating hyperreactio luteinalis following controlled ovarian hyperstimulation and in vitro fertilization

Abstract

We report a case of bilateral serous cystadenofibromas clinically simulating hyperreactio luteinalis during a normal pregnancy resulting from controlled ovarian stimulation and in vitro fertilization. Incomplete regression at 2-year follow-up prompted surgical intervention. This case demonstrates that the clinical and sonographic features that have been associated with hyperreactio luteinalis are not specific for this condition and emphasizes the need for close clinical follow-up in all presumptive cases for which a histologic diagnosis has not been established.

Full Text

The Full Text of this article is available as a PDF (689K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Joshi R, Dunaif A. Ovarian disorder during pregnancy. Endocrinol Metab Clin North Am. 1985;24:153–168. [PubMed]
2. Wajda KJ, Lucas J, Marsh WL. Hyperreactio luteinalis. Arch Pathol Lab Med. 1989;113:921–925. [PubMed]
3. Garcia-Bunuel R, Berek JS, Woodruff JD. Luteomas of pregnancy. Obstet Gynecol. 1975;45:407–414. [PubMed]
4. Hatjis C. Nonimmunologic fetal hydrops associated with hyperreactio luteinalis. Obstet Gynecol. 1985;65:11S–13S. [PubMed]
5. Levine S, Huffaker J, Jacobson J, Brodey P, Fisch A. Second-trimester spontaneous regression of theca lutein cysts. Obstet Gynecol. 1982;60:124–126. [PubMed]
6. Fayes J, Bunch T, Miller G. Virilization in pregnancy associated with an ovarian serous cystadenoma. Am J Obstet Gynecol. 1974;120:341–346. [PubMed]
7. Rossing M, Daling J, Weiss N, Moore D, Self S. Ovarian tumors in a cohort of infertile women. N Engl J Med. 1994;331:771–776. doi: 10.1056/NEJM199409223311204. [PubMed] [Cross Ref]
8. Harris R, Whittemore A, Itnyre J, Collaborative Ovarian Cancer Group Characteristics relating to ovarian cancer risk; Collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Am J Epidemiol. 1992;136:1204–1211. [PubMed]
9. Whittemore A, Harris R, Itnyre J, Collaborative Ovarian Cancer Group Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. II. Invasive epithelial cancers in white women. Am J. Epidemiol. 1992;136:1184–1203. [PubMed]
10. Scully R. Atlas of Tumor Pathology, Second Series. Washington, DC: Armed Forces Institute of Pathology; 1979. Tumors of the ovary and maldeveloped gonads.
11. Mittal K, Zeleniuch-Jacquotte A, Cooper J, Demopoulos R. Contralateral ovary in unilateral ovarian carcinoma: A search of preneoplastic lesions. Int J Gynecol Pathol. 1993;12:59–63. doi: 10.1097/00004347-199301000-00008. [PubMed] [Cross Ref]
12. Montz F, Schlaerth J, Morow C. The natural history of theca lutein cysts. Obstet Gynecol. 1988;72:247–251. [PubMed]
13. Schwartz PE. The role of tumor markers in the preoperative diagnosis of ovarian cysts. Clin Obstet Gynecol. 1993;36(2):384–394. doi: 10.1097/00003081-199306000-00017. [PubMed] [Cross Ref]
14. Ozaksit NO, Turhan, Oral H, Dogu N, Gokmen O. Relationship between serum CA 125 levels, endometrial thickness and corpus luteum function in different stages of ovarian activity. J Endocrinol Invest. 1993;16:175–179. [PubMed]

Articles from Journal of Assisted Reproduction and Genetics are provided here courtesy of Springer Science+Business Media, LLC